NCT00015340

Buprenorphine/Naloxone in the Treatment of Heroin Dependence - 14

Buprenorphine/Nx Treatment of Heroin Dependence-A Compassionate Use Study

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 582 (actual)
• Sponsor: National Institute on Drug Abuse (NIDA) · NIH
• Sex: All
• Age: 18 Years – 59 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is the safety and efficacy of Buprenorphine/Naloxone in the treatment of opioid dependence. A compassionate use study.

Detailed description

The objective of this study is to provide follow-up compassionate use treatment and evaluate long term safety and efficacy of a buprenorphine/naloxone combination tablet for opiate dependence treatment for subjects who have completed Cooperative Study 1008 A and B.

Conditions

• Opioid Dependence
• Substance-Related Disorders

Interventions

Type	Name	Description
DRUG	Buprenorphine/naloxone

Timeline

• Start date: 1999-08-01
• Primary completion: 2001-08-01
• Completion: 2001-09-01
• First posted: 2001-04-18
• Last updated: 2017-01-12

Locations

5 sites across 1 country: United States